188 related articles for article (PubMed ID: 30888545)
1. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
Bae YS; Chang J; Park SM
Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
[TBL] [Abstract][Full Text] [Related]
2. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
3. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ
Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
[TBL] [Abstract][Full Text] [Related]
4. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
6. Exposure to oral bisphosphonates and risk of cancer.
Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
8. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
9. An observational study of musculoskeletal pain among patients receiving bisphosphonate therapy.
Caplan L; Pittman CB; Zeringue AL; Scherrer JF; Wehmeier KR; Cunningham FE; Eisen SA; McDonald JR
Mayo Clin Proc; 2010 Apr; 85(4):341-8. PubMed ID: 20231335
[TBL] [Abstract][Full Text] [Related]
10. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
11. Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.
Prochaska M; Taylor E; Vaidya A; Curhan G
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1284-1290. PubMed ID: 28576907
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan.
Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY
J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379
[TBL] [Abstract][Full Text] [Related]
13. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
[TBL] [Abstract][Full Text] [Related]
15. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
Wang CC; Lu HT; Dusetzina SB; Wu CH
J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
[TBL] [Abstract][Full Text] [Related]
16. [Use of oral contraceptives and risk of cancer, a cohort study].
Kumle M; Alsaker E; Lund E
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
[TBL] [Abstract][Full Text] [Related]
17. Gynecologic and breast cancers in women after exposure to blue asbestos at Wittenoom.
Reid A; Segal A; Heyworth JS; de Klerk NH; Musk AW
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):140-7. PubMed ID: 19124491
[TBL] [Abstract][Full Text] [Related]
18. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
[TBL] [Abstract][Full Text] [Related]
19. Factors Affecting the Occurrence of Mental Health Problems in Female Cancer Survivors: A Nationwide Cohort Study.
Kim SY; Lee Y; Koh SB
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886467
[TBL] [Abstract][Full Text] [Related]
20. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.
Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G
Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
